Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe
Jarkko Piuhola1, Risto Kerkelä2, Mika Laine3
1Division of Cardiology, Department of Internal Medicine, Oulu University Hospital, Oulu, Finland.
Abstract:
We compared the ST elevation myocardial infarction (STEMI) incidence during COVID-19 pandemic (March 2020) to January-February 2020 and to same time period in earlier years 2017-2019 in five Nordic-Baltic tertiary centers. During 2017-2019, there were no marked differences in STEMI incidence between January, February and March. During 2020, there was an average drop of 32% in STEMI incidence in March. The isolation measures may decrease the risk for respiratory virus infection and contribute to the lower STEMI incidence and that we might benefit from firmer suggestions on hand hygiene and social distancing during flu season at least among high-risk individuals.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Coronary Syndrome III: Diagnostic Studies
